✦ LIBER ✦

Surgery is not superior to octreotide LAR in newly diagnosed patients with acromegaly

✍ Scribed by Annamaria Colao

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Critical appraisal of a randomized trial

✍ Rafael S. Scheffel; José M. Dora 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 39 KB

Octreotide LAR vs. surgery in newly diag

✍ Annamaria Colao; Paolo Cappabianca; Philippe Caron; Ernesto De Menis; Andrew J. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 354 KB

Comparison of primary octreotide-lar and

✍ Z. Karaca; F. Tanriverdi; G. Elbuken; I. Cakir; H. Donmez; A. Selcuklu; A. C. Du 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

A prospective, multicentre study to inve

✍ Moises Mercado; Fatima Borges; Hakim Bouterfa; Tien-Chun Chang; Alberto Chervin; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 332 KB

Efficacy of Sandostatin® LAR® (long-acti

✍ John Ayuk; Susan E. Stewart; Paul M. Stewart; Michael C. Sheppard; the European 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 292 KB

Upfront VIP-reinforced-ABVD (VIP-rABVD)

✍ Audrey Simon; Michel Peoch; Philippe Casassus; Eric Deconinck; Philippe Colombat 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 237 KB